ATE469170T1 - Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320 - Google Patents
Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320Info
- Publication number
- ATE469170T1 ATE469170T1 AT04749465T AT04749465T ATE469170T1 AT E469170 T1 ATE469170 T1 AT E469170T1 AT 04749465 T AT04749465 T AT 04749465T AT 04749465 T AT04749465 T AT 04749465T AT E469170 T1 ATE469170 T1 AT E469170T1
- Authority
- AT
- Austria
- Prior art keywords
- strain
- respiratory syncytial
- syncytial virus
- compositions
- methods
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 241000725643 Respiratory syncytial virus Species 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 241000711920 Human orthopneumovirus Species 0.000 abstract 1
- 108010088716 attachment protein G Proteins 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45833103P | 2003-03-28 | 2003-03-28 | |
| US50832003P | 2003-10-03 | 2003-10-03 | |
| PCT/US2004/009438 WO2004087062A2 (en) | 2003-03-28 | 2004-03-26 | Compositions and methods involving respiratory syncytial virus subgroup b strain 9320 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE469170T1 true ATE469170T1 (de) | 2010-06-15 |
Family
ID=33135096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04749465T ATE469170T1 (de) | 2003-03-28 | 2004-03-26 | Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US7572904B2 (de) |
| EP (1) | EP1613345B1 (de) |
| JP (1) | JP4783726B2 (de) |
| AT (1) | ATE469170T1 (de) |
| AU (1) | AU2004226369A1 (de) |
| CA (1) | CA2520671C (de) |
| DE (1) | DE602004027362D1 (de) |
| WO (1) | WO2004087062A2 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1572108A4 (de) * | 2002-09-27 | 2008-09-17 | Medimmune Vaccines Inc | Funktionale mutationen des rsv (respiratory syncytial virus) |
| ATE469170T1 (de) * | 2003-03-28 | 2010-06-15 | Medimmune Llc | Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320 |
| FR2885139B1 (fr) * | 2005-04-29 | 2010-12-24 | Agronomique Inst Nat Rech | Preparation de complexes solubles proteine n-proteine p tronquee ou de proteine n soluble d'un virus de la famille des paramyxoviridae et leurs utilisations vaccinales |
| EP1991694B1 (de) * | 2006-02-13 | 2016-04-13 | Fluidigm Canada Inc. | Genexpressionsanalyse mit element-tag-oligonukleotid |
| KR20080113223A (ko) * | 2006-03-06 | 2008-12-29 | 심포젠 에이/에스 | 호흡기세포 융합 바이러스 감염 치료용 재조합 폴리클로날 항체 |
| FR2899902B1 (fr) * | 2006-04-18 | 2012-01-27 | Agronomique Inst Nat Rech | Proteines de fusion proteine n d'un virus de la famille des paramyxoviridae-proteine d'interet et leurs utilisations pour la vaccination et la vectorisation intra-cellulaire. |
| CA2678628A1 (en) * | 2007-03-06 | 2008-09-12 | Symphogen A/S | Recombinant antibodies for treatment of respiratory syncytial virus infections |
| EP2069485A4 (de) * | 2007-07-13 | 2011-05-25 | Medimmune Llc | Zubereitung von negativstrang-rna-viren mittels elektroporation |
| US8354230B2 (en) * | 2007-12-21 | 2013-01-15 | Quest Diagnostics Investments Inc. | Multiplex detection assay for influenza and RSV viruses |
| BRPI0921424A2 (pt) * | 2008-11-05 | 2016-01-05 | Merck Sharp & Dohme | vírus sincicial respiratório atenuado, composição imunogênica, molécula de ácido nucléico, célula recombinante, método para produzir uma resposta imune protetiva em um paciente, e, uso de uma quantidade imunologicamente eficaz de um ou mais dos seguintes: um rsv atenuado, uma população de rsv atenuado e uma composição imunogênica. |
| GB201019240D0 (en) | 2010-11-15 | 2010-12-29 | Vib Vzw | Respiratory syncytical virus vaccine |
| US10227569B2 (en) | 2011-04-12 | 2019-03-12 | Emory University | Respiratory syncytial virus expression vectors |
| CN105189756B (zh) | 2013-03-14 | 2021-06-11 | 爱默蕾大学 | 具有沉默突变的重组rsv、其相关疫苗和方法 |
| US11235050B2 (en) | 2015-10-29 | 2022-02-01 | Emory University | Chimeric RSV, immunogenic compositions, and methods of use |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4800078A (en) * | 1987-05-28 | 1989-01-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb |
| US5840520A (en) * | 1989-08-28 | 1998-11-24 | Aviron | Recombinant negative strand RNA virus expression systems |
| GB9200117D0 (en) | 1992-01-06 | 1992-02-26 | Connaught Lab | Production of recombinant chimeric proteins for vaccine use |
| IL105456A (en) * | 1992-04-21 | 1996-12-05 | American Home Prod | Vaccines of attenuated respiratory syncytial virus |
| US20030054505A1 (en) * | 1997-09-26 | 2003-03-20 | Hong Jin | Recombinant rsv expression systems and vaccines |
| US6713066B1 (en) | 1996-07-15 | 2004-03-30 | The United States Of America As Represented By The Department Of Health And Human Services | Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2 |
| AU4427897A (en) * | 1996-09-27 | 1998-04-17 | American Cyanamid Company | 3' genomic promoter region and polymerase gene mutations responsible for att enuation in viruses of the order designated mononegavirales |
| US6017694A (en) | 1997-12-19 | 2000-01-25 | American Cyanamid Company | Methods of screening for modulators of respiratory syncytial virus matrix protein interaction |
| EP1064358A2 (de) * | 1998-03-26 | 2001-01-03 | American Cyanamid Company | Mutationen die für abschwächung von masern-virus oder von menschlichen respiratorischen synzytialvirus verantwortlich sind |
| CA2430115C (en) | 2000-11-28 | 2013-02-26 | Aviron, Inc. | Recombinant rsv virus expression systems and vaccines |
| NZ527221A (en) | 2001-01-19 | 2006-09-29 | Vironovative B | A negative-sense single stranded RNA virus causing respiratory tract illness in susceptible mammals |
| EP1572108A4 (de) * | 2002-09-27 | 2008-09-17 | Medimmune Vaccines Inc | Funktionale mutationen des rsv (respiratory syncytial virus) |
| ATE469170T1 (de) * | 2003-03-28 | 2010-06-15 | Medimmune Llc | Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320 |
-
2004
- 2004-03-26 AT AT04749465T patent/ATE469170T1/de not_active IP Right Cessation
- 2004-03-26 JP JP2006509391A patent/JP4783726B2/ja not_active Expired - Fee Related
- 2004-03-26 AU AU2004226369A patent/AU2004226369A1/en not_active Abandoned
- 2004-03-26 EP EP04749465A patent/EP1613345B1/de not_active Expired - Lifetime
- 2004-03-26 CA CA2520671A patent/CA2520671C/en not_active Expired - Fee Related
- 2004-03-26 WO PCT/US2004/009438 patent/WO2004087062A2/en active Application Filing
- 2004-03-26 US US10/811,508 patent/US7572904B2/en not_active Expired - Lifetime
- 2004-03-26 DE DE602004027362T patent/DE602004027362D1/de not_active Expired - Lifetime
-
2009
- 2009-07-23 US US12/508,075 patent/US8163530B2/en not_active Expired - Lifetime
-
2012
- 2012-04-17 US US13/449,087 patent/US20120263744A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US7572904B2 (en) | 2009-08-11 |
| EP1613345A2 (de) | 2006-01-11 |
| JP2006524053A (ja) | 2006-10-26 |
| US8163530B2 (en) | 2012-04-24 |
| WO2004087062A2 (en) | 2004-10-14 |
| EP1613345B1 (de) | 2010-05-26 |
| CA2520671A1 (en) | 2004-10-14 |
| JP4783726B2 (ja) | 2011-09-28 |
| WO2004087062A3 (en) | 2005-03-31 |
| US20090285853A1 (en) | 2009-11-19 |
| EP1613345A4 (de) | 2007-01-10 |
| DE602004027362D1 (de) | 2010-07-08 |
| US20120263744A1 (en) | 2012-10-18 |
| US20040224309A1 (en) | 2004-11-11 |
| AU2004226369A1 (en) | 2004-10-14 |
| CA2520671C (en) | 2014-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL300897I2 (nl) | Neisseira meningitidis serogroep B recombinant gelipideerd fHbp subfamilie A05 eiwit | |
| DE69922958D1 (de) | Hcv hüllproteine partikel : verwendung für therapeutische impfung | |
| CA2253636A1 (en) | Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof | |
| ATE469170T1 (de) | Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320 | |
| ATE348883T1 (de) | Zusammensetzungen und verfahren mit analogen von g-csf | |
| WO2003086451A8 (en) | Asthma-related anti-il-13 immunoglobulin derived proteins, compositions, methods and uses | |
| DE602004023725D1 (de) | Muteine von tränen-lipocalin | |
| EA199900355A1 (ru) | Теломераза обратная тринскриптаза | |
| AU6160201A (en) | Human polypeptides causing or leading to the killing of cells including lymphoidtumor cells | |
| ES2353814T3 (es) | Proteinas n-glicosiladas recombinantes de celulas procariotas. | |
| HUP0302965A2 (hu) | Vakcina | |
| WO2006038908A3 (en) | Ancestral and cot viral sequences, proteins and immunogenic compositions | |
| WO2008033375A3 (en) | Long lasting drug formulations | |
| BRPI0411363A (pt) | seqüências de ácidos nucléicos codificando e composições compreendendo peptìdeo sinal ige e/ou il-15 e processos para uso das mesmas | |
| WO2004085633A8 (en) | A novel human virus causing severe acute respiratory syndrome (sars) and uses thereof | |
| WO2004035732A3 (en) | Human polypeptides encoded by polynucleotides and methods of their use | |
| ATE543833T1 (de) | Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen | |
| MXPA05005202A (es) | Vacuna. | |
| WO2005035558A3 (en) | Piscirickettsia salmonis antigens and use thereof | |
| WO2000012535A3 (en) | Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof | |
| WO2005011571A3 (en) | Hepatitis virus core proteins as vaccine platforms and methods of use thereof | |
| HUP0100267A2 (hu) | Helicobacter pylori eredetű nukleinsav- és aminosav-szekvenciák és a megfelelő nukleinsavakat vagy peptideket tartalmazó vakcina-készítmények | |
| WO1999058639A3 (en) | Structural proteins of fish pancreatic disease virus and uses thereof | |
| WO2001055353A3 (en) | Recombinant attenuation of prrsv | |
| WO2004020591A3 (en) | Methods of use for novel human polypeptides encoded by polynucleotides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |